Pacira BioSciences
(NASDAQ:PCRX)
$29.86
0[0.00%]
At close: May 10
$29.86
0[0.00%]
After Hours: 4:03PM EDT
Q1 2024 Earnings were released on Tue May 7th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Pacira BioSciences Stock (NASDAQ:PCRX), Quotes and News Summary

Pacira BioSciences Stock (NASDAQ: PCRX) stock price, news, charts, stock research, profile.

Open$29.860
Close$29.420
Volume / Avg.5.644M / 518.260K
Day Range29.140 - 30.700
52 Wk Range25.330 - 43.500
Market Cap$1.390B
P/E Ratio19.775
Dividend Yield-
ExchangeNASDAQ
RSI
65
Short Interest
10.74%
Days to Cover8.62

Recent News

Why Pacira BioSciences Shares Are Trading Lower Today
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the 
Vandana Singh
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Lisa Levin
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
Vandana Singh
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Feb
4
Mar
1
Apr
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PCRX
SUPN

FAQ

Q

How do I buy Pacira BioSciences (PCRX) stock?

A

You can purchase shares of Pacira BioSciences (NASDAQ: PCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pacira BioSciences's (PCRX) competitors?

A

Other companies in Pacira BioSciences’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).

Q

What is the target price for Pacira BioSciences (PCRX) stock?

A

The latest price target for Pacira BioSciences (NASDAQ: PCRX) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 57.00 expecting PCRX to rise to within 12 months (a possible 90.89% upside). 24 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Pacira BioSciences (PCRX)?

A

The stock price for Pacira BioSciences (NASDAQ: PCRX) is $29.86 last updated May 10, 2024 at 4:03 PM EDT.

Q

Does Pacira BioSciences (PCRX) pay a dividend?

A

There are no upcoming dividends for Pacira BioSciences.

Q

When is Pacira BioSciences (NASDAQ:PCRX) reporting earnings?

A

Pacira BioSciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is Pacira BioSciences (PCRX) going to split?

A

There is no upcoming split for Pacira BioSciences.

Q

What sector and industry does Pacira BioSciences (PCRX) operate in?

A

Pacira BioSciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch